The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gibertini Michael since 2015.
The trader's CIK number is 1630998.
At the time of the last reporting, Gibertini Michael was the President Clinical Development of Syneos Health, Inc.. (stock ticker symbol SYNH).
Also see all insider trading activities at Syneos Health, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | INCR | 0 | $0 | 0 | $0 | 21,567 | $0 |
| 2016 | INCR | 0 | $0 | 249,966 | $10,814,108 | 222,096 | $2,480,220 |
| 2015 | INCR | 0 | $0 | 68,000 | $2,278,663 | 18,000 | $152,100 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-08-01 | INCR | Option Ex | 21,567 | .00 | 0 |
| 2016-06-06 | INCR | Sale | 213,966 | 43.45 | 9,296,394 |
| 2016-06-06 | INCR | Option Ex | 186,096 | 11.69 | 2,176,020 |
| 2016-04-01 | INCR | Sale | 9,000 | 40.78 | 367,037 |
| 2016-04-01 | INCR | Option Ex | 9,000 | 8.45 | 76,050 |
| 2016-03-01 | INCR | Option Ex | 9,000 | 8.45 | 76,050 |
| 2016-03-01 | INCR | Sale | 9,000 | 39.85 | 358,677 |
| 2016-02-01 | INCR | Option Ex | 9,000 | 8.45 | 76,050 |
| 2016-02-01 | INCR | Sale | 9,000 | 41.01 | 369,045 |
| 2016-01-04 | INCR | Option Ex | 9,000 | 8.45 | 76,050 |
| 2016-01-04 | INCR | Sale | 9,000 | 46.99 | 422,955 |
| 2015-12-01 | INCR | Option Ex | 9,000 | 8.45 | 76,050 |
| 2015-12-01 | INCR | Sale | 9,000 | 46.60 | 419,363 |
| 2015-11-02 | INCR | Option Ex | 9,000 | 8.45 | 76,050 |
| 2015-11-02 | INCR | Sale | 9,000 | 41.70 | 375,300 |
| 2015-05-07 | INCR | Sale | 50,000 | 29.68 | 1,484,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gibertini Michael (President Clinical Development of Syneos Health, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.